Hot Topics I: A Potpourri of Current Issues and Controversies in Thrombosis and Hemostasis

REFERENCES

• 1 Brown J E, Bosak J O. An ELISA test for the binding of von Willebrand antigen to collagen.  Thromb Res. 1986;  43 303-311
• 2 Favaloro E J. von Willebrand factor (VWF) collagen binding (activity) assay (VWF:CBA) in the diagnosis of von Willebrand's disorder (VWD): A 15-year journey.  Semin Thromb Hemost. 2002;  28 191-202
• 3 U.S. Food and Drug Administration . Center for Drug Evaluation and Research. Genomics at FDA.  Available at: http://www.fda.gov/cder/genomics/ Accessed October 17, 2007; 
• 4 Veenstra D L. The cost-effectiveness of warfarin pharmacogenomics.  J Thromb Haemost. 2007;  5 1974-1975
• 5 Enayat M S, Guilliatt A M, Lester W, Wilde J T, Williams M D, Hill F G. Distinguishing between type 2B and pseudo-von Willebrand disease and its clinical importance.  Br J Haematol. 2006;  133 664-666
• 6 Favaloro E J. 2B or not 2B? Differential identification of type 2B, versus pseudo-von Willebrand disease.  Br J Haematol. 2006;  135 141-142
• 7 Whalley I N, Perry D J. 2B or not 2B? Differential identification of type 2B, versus pseudo-, von Willebrand disease.  Br J Haematol. 2007;  136 345
• 8 Favaloro E. 2B or not 2B? Differential identification of type 2B, versus pseudo-, von Willebrand disease-response to Whalley and Perry.  Br J Haematol. 2007;  136 345-349
• 9 Othman M, Lillicrap D. Distinguishing between non-identical twins: platelet type and type 2B von Willebrand disease.  Br J Haematol. 2007;  138 665-666
• 10 Favaloro E J, Patterson D, Denholm A et al.. Differential identification of a rare form of platelet-type (pseudo-) von Willebrand disease (VWD) from type 2B VWD using a simplified ristocetin-induced-platelet-agglutination mixing assay and confirmed by genetic analysis.  Br J Haematol. 2007;  139 623-626
• 11 Franchini M. Hemostasis and aging.  Crit Rev Oncol Hematol. 2006;  60 144-151